Ben Lamm
Ben Lamm is an American entrepreneur and the co-founder and CEO of Colossal Biosciences, a Dallas-based biotechnology company focused on de-extinction and genetic engineering. He co-founded the company in 2021 with Harvard geneticist George Church to develop technologies for restoring extinct species, including the woolly mammoth, dodo bird, and Tasmanian tiger, using CRISPR and other genetic tools. Lamm previously founded several technology companies, including Chaotic Moon Studios, Conversable, and Hypergiant Industries, each of which was acquired.
“$12B valuation, $635M raised including a $400M round that doubled from its $200M target. 260+ employees, 55,000 sq ft Texas HQ, six species in de-extinction portfolio, three sets of live engineered animals produced.”
Source→“Astromech builds predictive models of biological change trained on 3.8 billion years of evolutionary history. Applications span cancer, drug resistance, biosecurity, agriculture, and conservation.”
Source→“Extinction is a systems model. Genetic engineering from taking a 73,000-year-old skull and going to puppies is a systems model.”
Source→“You're going to see this pre-Cambrian explosion of new drugs and new therapies that all come from AI-assisted drug design discovery.”
Source→“Having zero background in biology and biotech, I couldn't be more qualified to run this company... Extinction is a systems model, genetic engineering is a systems model.”
Source→“The ability to preserve, engineer and direct life on a planetary scale, in all species, I think is a pretty important skillset for humanity.”
Source→“We had 100% healthy mice born with exactly the predicted phenotypes, with the most multiplex edited, delivered at one time ever. And we did it in 30 days.”
Source→“CEO Ben Lamm told Rolling Stone in May that he expects to create an artificial womb for mammals within a year, opening the door to human usage.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.